Young German Woman's Life Upended by Severe ME/CFS Diagnosis
Melanie, a 26-year-old woman from Germany, has been battling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) since early September 2025. The condition began after a cold worsened into a debilitating illness, leaving her dependent on her partner, Claas, for daily care. ME/CFS is a severe neuroimmunological disease affecting millions globally, including around 1.4 million people in Germany alone. Mel and Claas, both 26, have been together for eight years after meeting during their undergraduate studies. Claas, who works as a financial controller, now manages her care after her last crash two weeks ago left her unable to feed herself. Her symptoms include severe exhaustion, rapid heartbeat, dizziness, and muscle pain—common in ME/CFS patients.
Recently, Mel experienced post-exertional malaise (PEM), where even minor activity triggers a dramatic decline in her health. To support her, Claas obtained a power of attorney, allowing him to make medical and professional decisions on her behalf. The German government has already allocated €500 million to ME/CFS research, reflecting the growing recognition of the disease’s impact. Despite this, many patients like Mel still face daily struggles with basic tasks and long-term uncertainty.
Mel’s condition highlights the severe challenges of living with ME/CFS, a disease that disrupts even simple activities. With Claas now managing her care, the couple navigates a difficult reality shared by millions in Germany and beyond. Research funding continues, but for patients like Mel, each day remains a battle against debilitating symptoms.
